Poor response to gefitinib in lung adenocarcinoma with concomitant epidermal growth factor receptor mutation and anaplastic lymphoma kinase rearrangement

A patient presenting with concomitant epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) translocation is rare. We report a non-small cell lung cancer (NSCLC) patient with concomitant ALK rearrangement and exon 19 (E746-A750del) EGFR mutation. The ALK rearrangement...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jianya, Zheng, Jing, Zhao, Jing, Sheng, Yihong, Ding, Wei, Zhou, Jianying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448493/
https://www.ncbi.nlm.nih.gov/pubmed/26273361
http://dx.doi.org/10.1111/1759-7714.12146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448493/
https://www.ncbi.nlm.nih.gov/pubmed/26273361
http://dx.doi.org/10.1111/1759-7714.12146

Ejemplares similares